Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06605534 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Leveraging the Emergency Department (LEAD) Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 months later Oct 30, 2026 → Dec 31, 2026
See other at-risk trials from Hackensack Meridian Health

Record History

  1. Primary and study completion pushed from Oct 30, 2026 to Dec 31, 2026v9
  2. 4 versions Re-verified since Jan 7, 2025, no change to tracked fieldsv5-v8
  3. Study sites: 1 to 10v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 1, 2024 to Oct 29, 2024
    v3
  5. Start date: Oct 1, 2024 to Nov 1, 2024
    • Primary and study completion dates: Sep 30, 2026 to Oct 30, 2026
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a pilot Type 1 Hybrid Effectiveness-Implementation Trial. The study will first examine reach in a non-traditional setting (the Emergency Department - ED) that uses an Electronic Health Record (EHR)-embedded Social Determinants of Health (SDoH) screening tool to identify lung screening-eligible patients for a tailored intervention to increase lung screening uptake. Reach is defined as the absolute number, proportion, and representativeness of individuals targeted for lung screening knowledge, awareness, and uptake. Then, a pilot trial will be conducted to examine the preliminary effectiveness of a tailored lung screening intervention compared to enhanced usual care to influence individual-level potential drivers of lung screening (health literacy, mistrust, stigma, fatalism, knowledge, lung screening health beliefs) and the ability to increase lung screening uptake among screening-eligible patients. Quantitative (Randomized Controlled Trial and EHR data) methods will be used for data collection and analysis to address the study aims.
Trial Details
NCT Number NCT06605534
Lead Sponsor Hackensack Meridian Health
Collaborators: New Jersey Commission on Cancer Research
Conditions
(from sponsor)		 Lung Cancer
Related terms Emergencies, Lung Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov